Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myflora comfort
- Development stage
- Unknown
- Lead developer
- biosyn Arzneimittel
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Myflora Comfort is an oral dietary supplement developed and marketed by biosyn Arzneimittel GmbH to support intestinal health and the gut microbiome. The product is formulated as a 'sporebiotic,' containing two specific bacterial strains in spore form: *Bacillus coagulans* (ATCC 7050) and *Bacillus subtilis* (LMG P-31319). These spore-forming bacteria are characterized by their high stability against stomach acid and long shelf life. In addition to the probiotic cultures, Myflora Comfort contains botanical ingredients, including artichoke extract and acacia fibers, which serve as prebiotics and support digestive function. It is available in German pharmacies as a non-prescription supplement in capsule form.
- Brand names
- myflora comfort
- Other names
- Myflora Comfort
Beyond the preview
Go deeper on myflora comfort.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myflora comfort.